U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 233

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr12:121416289
GRCh38:
Chr12:120978486
HNF1AMonogenic diabetesLikely pathogenic
(Aug 18, 2021)
reviewed by expert panel
FDA Recognized Database
2.
GRCh37:
Chr12:121416447
GRCh38:
Chr12:120978644
HNF1AMaturity-onset diabetes of the young type 3Pathogenic
(Jan 1, 2000)
no assertion criteria provided
3.
GRCh37:
Chr12:121416572
GRCh38:
Chr12:120978769
HNF1AM1LMonogenic diabetesLikely pathogenic
(Mar 4, 2022)
reviewed by expert panel
FDA Recognized Database
4.
GRCh37:
Chr12:121416572
GRCh38:
Chr12:120978769
HNF1AM1LMonogenic diabetesPathogenic
(Mar 4, 2022)
reviewed by expert panel
FDA Recognized Database
5.
GRCh37:
Chr12:121416572
GRCh38:
Chr12:120978769
HNF1AM1VMonogenic diabetesPathogenic
(Mar 4, 2022)
reviewed by expert panel
FDA Recognized Database
6.
GRCh37:
Chr12:121416573
GRCh38:
Chr12:120978770
HNF1AM1TMonogenic diabetesPathogenic
(Aug 26, 2022)
reviewed by expert panel
FDA Recognized Database
7.
GRCh37:
Chr12:121416574
GRCh38:
Chr12:120978771
HNF1AV2fsMonogenic diabetesPathogenic
(Feb 22, 2022)
reviewed by expert panel
FDA Recognized Database
8.
GRCh37:
Chr12:121416587
GRCh38:
Chr12:120978784
HNF1AS6CMonogenic diabetesLikely pathogenic
(Mar 4, 2022)
reviewed by expert panel
FDA Recognized Database
9.
GRCh37:
Chr12:121416588
GRCh38:
Chr12:120978785
HNF1AS6NMonogenic diabetesLikely pathogenic
(Mar 4, 2022)
reviewed by expert panel
FDA Recognized Database
10.
GRCh37:
Chr12:121416590-121416591
GRCh38:
Chr12:120978787-120978788
HNF1AMonogenic diabetesLikely pathogenic
(Mar 25, 2022)
reviewed by expert panel
FDA Recognized Database
11.
GRCh37:
Chr12:121416590
GRCh38:
Chr12:120978787
HNF1AQ7*Monogenic diabetesPathogenic
(Mar 18, 2022)
reviewed by expert panel
FDA Recognized Database
12.
GRCh37:
Chr12:121416596
GRCh38:
Chr12:120978793
HNF1AQ9*Monogenic diabetesPathogenic
(Mar 25, 2022)
reviewed by expert panel
FDA Recognized Database
13.
GRCh37:
Chr12:121416597
GRCh38:
Chr12:120978794
HNF1AQ9LMaturity-onset diabetes of the young type 3Likely pathogeniccriteria provided, single submitter
14.
GRCh37:
Chr12:121416599
GRCh38:
Chr12:120978796
HNF1AT10PMonogenic diabetesLikely pathogenic
(Mar 25, 2022)
reviewed by expert panel
FDA Recognized Database
15.
GRCh37:
Chr12:121416605
GRCh38:
Chr12:120978802
HNF1AL12FMonogenic diabetesLikely pathogenic
(Mar 25, 2022)
reviewed by expert panel
FDA Recognized Database
16.
GRCh37:
Chr12:121416605
GRCh38:
Chr12:120978802
HNF1AL12VMonogenic diabetesLikely pathogenic
(Mar 25, 2022)
reviewed by expert panel
FDA Recognized Database
17.
GRCh37:
Chr12:121416606
GRCh38:
Chr12:120978803
HNF1AL12RMonogenic diabetesLikely pathogenic
(Mar 30, 2022)
reviewed by expert panel
FDA Recognized Database
18.
GRCh37:
Chr12:121416613-121416622
GRCh38:
Chr12:120978810-120978819
HNF1AA15fsMonogenic diabetesPathogenic
(Mar 31, 2022)
reviewed by expert panel
FDA Recognized Database
19.
GRCh37:
Chr12:121416623
GRCh38:
Chr12:120978820
HNF1AE18*Maturity onset diabetes mellitus in young, Maturity-onset diabetes of the young type 3Pathogenic/Likely pathogenic
(Aug 2, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr12:121416629
GRCh38:
Chr12:120978826
HNF1AG20RMonogenic diabetesLikely pathogenic
(Aug 18, 2021)
reviewed by expert panel
FDA Recognized Database
21.
GRCh37:
Chr12:121416629
GRCh38:
Chr12:120978826
HNF1AG20RMonogenic diabetesPathogenic
(Aug 18, 2021)
reviewed by expert panel
FDA Recognized Database
22.
GRCh37:
Chr12:121416630
GRCh38:
Chr12:120978827
HNF1AG20EMonogenic diabetesLikely pathogenic
(Aug 18, 2021)
reviewed by expert panel
FDA Recognized Database
23.
GRCh37:
Chr12:121416630
GRCh38:
Chr12:120978827
HNF1AG20AMonogenic diabetesLikely pathogenic
(Aug 18, 2021)
reviewed by expert panel
FDA Recognized Database
24.
GRCh37:
Chr12:121416630
GRCh38:
Chr12:120978827
HNF1AG20Vnot providedLikely pathogenic
(Sep 16, 2018)
no assertion criteria provided
25.
GRCh37:
Chr12:121416640-121416641
GRCh38:
Chr12:120978837-120978838
HNF1AE24fsMonogenic diabetesPathogenic
(Apr 1, 2022)
reviewed by expert panel
FDA Recognized Database
26.
GRCh37:
Chr12:121416648
GRCh38:
Chr12:120978845
HNF1AL26PMonogenic diabetesLikely pathogenic
(Apr 2, 2022)
reviewed by expert panel
FDA Recognized Database
27.
GRCh37:
Chr12:121416653
GRCh38:
Chr12:120978850
HNF1AQ28*Monogenic diabetesLikely pathogenic
(Feb 8, 2022)
reviewed by expert panel
FDA Recognized Database
28.
GRCh37:
Chr12:121416665
GRCh38:
Chr12:120978862
HNF1AE32*Monogenic diabetesPathogenic
(Apr 2, 2022)
reviewed by expert panel
FDA Recognized Database
29.
GRCh37:
Chr12:121416669
GRCh38:
Chr12:120978866
HNF1AP33LMonogenic diabetesLikely pathogenic
(Apr 2, 2022)
reviewed by expert panel
FDA Recognized Database
30.
GRCh37:
Chr12:121416676-121416686
GRCh38:
Chr12:120978873-120978883
HNF1AY36fsnot providedPathogenic
(Apr 18, 2019)
criteria provided, single submitter
31.
GRCh37:
Chr12:121416692
GRCh38:
Chr12:120978889
HNF1AE41*Monogenic diabetesPathogenic
(Apr 2, 2022)
reviewed by expert panel
FDA Recognized Database
32.
GRCh37:
Chr12:121416697
GRCh38:
Chr12:120978894
HNF1AL44fsMonogenic diabetesPathogenic
(Apr 2, 2022)
reviewed by expert panel
FDA Recognized Database
33.
GRCh37:
Chr12:121416700-121416701
GRCh38:
Chr12:120978897-120978898
HNF1AL44fsMonogenic diabetesPathogenic
(May 4, 2022)
reviewed by expert panel
FDA Recognized Database
34.
GRCh37:
Chr12:121416709-121416725
GRCh38:
Chr12:120978906-120978922
HNF1AG47fsMaturity onset diabetes mellitus in youngLikely pathogenic
(Mar 8, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr12:121416709
GRCh38:
Chr12:120978906
HNF1AE48fsMonogenic diabetesPathogenic
(Apr 2, 2022)
reviewed by expert panel
FDA Recognized Database
36.
GRCh37:
Chr12:121416717
GRCh38:
Chr12:120978914
HNF1AS49Ynot providedLikely pathogenic
(Dec 9, 2020)
criteria provided, single submitter
37.
GRCh37:
Chr12:121416721
GRCh38:
Chr12:120978918
HNF1AC50*Maturity onset diabetes mellitus in youngPathogenic
(Mar 3, 2017)
criteria provided, single submitter
38.
GRCh37:
Chr12:121416731
GRCh38:
Chr12:120978928
HNF1AR54GMaturity onset diabetes mellitus in youngPathogeniccriteria provided, single submitter
39.
GRCh37:
Chr12:121416731
GRCh38:
Chr12:120978928
HNF1AR54*Monogenic diabetesPathogenic
(Dec 28, 2021)
reviewed by expert panel
FDA Recognized Database
40.
GRCh37:
Chr12:121416732-121416736
GRCh38:
Chr12:120978929-120978933
HNF1AG55fsMonogenic diabetesPathogenic
(Apr 2, 2022)
reviewed by expert panel
FDA Recognized Database
41.
GRCh37:
Chr12:121416740
GRCh38:
Chr12:120978937
HNF1AL57fsMonogenic diabetesLikely pathogenic
(Apr 3, 2022)
reviewed by expert panel
FDA Recognized Database
42.
GRCh37:
Chr12:121416755
GRCh38:
Chr12:120978952
HNF1AN62fsMonogenic diabetesPathogenic
(Apr 3, 2022)
reviewed by expert panel
FDA Recognized Database
43.
GRCh37:
Chr12:121416757
GRCh38:
Chr12:120978954
HNF1AN62fsMonogenic diabetesLikely pathogenic
(Apr 3, 2022)
reviewed by expert panel
FDA Recognized Database
44.
GRCh37:
Chr12:121416762-121416763
GRCh38:
Chr12:120978959-120978960
HNF1AE66fsMonogenic diabetesPathogenic
(Apr 3, 2022)
reviewed by expert panel
FDA Recognized Database
45.
GRCh37:
Chr12:121416774
GRCh38:
Chr12:120978971
HNF1AG69fsMonogenic diabetesLikely pathogenic
(Apr 4, 2022)
reviewed by expert panel
FDA Recognized Database
46.
GRCh37:
Chr12:121416782
GRCh38:
Chr12:120978979
HNF1AE71*not providedPathogenic
(Mar 3, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr12:121416788
GRCh38:
Chr12:120978985
HNF1AE73*Monogenic diabetesLikely pathogenic
(Apr 4, 2022)
reviewed by expert panel
FDA Recognized Database
48.
GRCh37:
Chr12:121416830
GRCh38:
Chr12:120979027
HNF1AK87*Monogenic diabetesLikely pathogenic
(Apr 6, 2022)
reviewed by expert panel
FDA Recognized Database
49.
GRCh37:
Chr12:121416833
GRCh38:
Chr12:120979030
HNF1AE88*not providedPathogenic
(Oct 14, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr12:121416852-121416853
GRCh38:
Chr12:120979049-120979050
HNF1AE95*Monogenic diabetesLikely pathogenic
(Apr 7, 2022)
reviewed by expert panel
FDA Recognized Database
51.
GRCh37:
Chr12:121416882-121416883
GRCh38:
Chr12:120979079-120979080
HNF1AE105fsMonogenic diabetesLikely pathogenic
(Apr 7, 2022)
reviewed by expert panel
FDA Recognized Database
52.
GRCh37:
Chr12:121416890
GRCh38:
Chr12:120979087
HNF1AL107IMonogenic diabetesLikely pathogenic
(Aug 19, 2021)
reviewed by expert panel
FDA Recognized Database
53.
GRCh37:
Chr12:121416891
GRCh38:
Chr12:120979088
HNF1AL107PMonogenic diabetesLikely pathogenic
(Sep 15, 2021)
reviewed by expert panel
FDA Recognized Database
54.
GRCh37:
Chr12:121416891
GRCh38:
Chr12:120979088
HNF1AL107RMonogenic diabetesLikely pathogenic
(Sep 15, 2021)
reviewed by expert panel
FDA Recognized Database
55.
GRCh37:
Chr12:121416898
GRCh38:
Chr12:120979095
HNF1AMonogenic diabetesPathogenic
(Jun 10, 2022)
reviewed by expert panel
FDA Recognized Database
56.
GRCh37:
Chr12:121416898
GRCh38:
Chr12:120979095
HNF1AMonogenic diabetesPathogenic
(Jun 10, 2022)
reviewed by expert panel
FDA Recognized Database
57.
GRCh37:
Chr12:121416898
GRCh38:
Chr12:120979095
HNF1AMonogenic diabetesPathogenic
(Jun 10, 2022)
reviewed by expert panel
FDA Recognized Database
58.
GRCh37:
Chr12:121416899
GRCh38:
Chr12:120979096
HNF1AMonogenic diabetesLikely pathogenic
(Apr 7, 2022)
reviewed by expert panel
FDA Recognized Database
59.
GRCh37:
Chr12:121426633-121426635
GRCh38:
Chr12:120988830-120988832
HNF1AMaturity onset diabetes mellitus in young, not providedPathogenic/Likely pathogenic
(Oct 17, 2019)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr12:121426634
GRCh38:
Chr12:120988831
HNF1AMonogenic diabetesLikely pathogenic
(Apr 17, 2022)
reviewed by expert panel
FDA Recognized Database
61.
GRCh37:
Chr12:121426635
GRCh38:
Chr12:120988832
HNF1AMonogenic diabetesPathogenic
(Aug 5, 2022)
reviewed by expert panel
FDA Recognized Database
62.
GRCh37:
Chr12:121426635
GRCh38:
Chr12:120988832
HNF1AMonogenic diabetesPathogenic
(Apr 18, 2022)
reviewed by expert panel
FDA Recognized Database
63.
GRCh37:
Chr12:121426644
GRCh38:
Chr12:120988841
HNF1AP112LMonogenic diabetesPathogenic
(Apr 8, 2022)
reviewed by expert panel
FDA Recognized Database
64.
GRCh37:
Chr12:121426647
GRCh38:
Chr12:120988844
HNF1AW113*Maturity onset diabetes mellitus in youngPathogeniccriteria provided, single submitter
65.
GRCh37:
Chr12:121426650-121426651
GRCh38:
Chr12:120988847-120988848
HNF1AV115fsMonogenic diabetesLikely pathogenic
(Feb 8, 2022)
reviewed by expert panel
FDA Recognized Database
66.
GRCh37:
Chr12:121426656
GRCh38:
Chr12:120988853
HNF1AA116VMaturity-onset diabetes of the young type 3Pathogenic
(Aug 2, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr12:121426674
GRCh38:
Chr12:120988871
HNF1AY122CMonogenic diabetesLikely pathogenic
(Aug 19, 2021)
reviewed by expert panel
FDA Recognized Database
68.
GRCh37:
Chr12:121426675
GRCh38:
Chr12:120988872
HNF1AY122*not providedPathogenic
(Nov 4, 2020)
criteria provided, single submitter
69.
GRCh37:
Chr12:121426677-121426678
GRCh38:
Chr12:120988874-120988875
HNF1AMonogenic diabetesLikely pathogenic
(Apr 10, 2022)
reviewed by expert panel
FDA Recognized Database
70.
GRCh37:
Chr12:121426679
GRCh38:
Chr12:120988876
HNF1AQ124*Maturity onset diabetes mellitus in young, not providedPathogenic
(May 4, 2018)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr12:121426686
GRCh38:
Chr12:120988883
HNF1AH126Rnot providedPathogenic
(Mar 3, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr12:121426686-121426688
GRCh38:
Chr12:120988883-120988885
HNF1AN127delMonogenic diabetesLikely pathogenic
(Jun 15, 2022)
reviewed by expert panel
FDA Recognized Database
73.
GRCh37:
Chr12:121426697
GRCh38:
Chr12:120988894
HNF1AQ130*Maturity onset diabetes mellitus in young, not providedPathogenic
(Sep 17, 2019)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr12:121426700
GRCh38:
Chr12:120988897
HNF1AR131WMonogenic diabetesPathogenic
(Aug 18, 2021)
reviewed by expert panel
FDA Recognized Database
75.
GRCh37:
Chr12:121426701
GRCh38:
Chr12:120988898
HNF1AR131QMonogenic diabetesPathogenic
(Aug 11, 2021)
reviewed by expert panel
FDA Recognized Database
76.
GRCh37:
Chr12:121426701
GRCh38:
Chr12:120988898
HNF1AR131LMonogenic diabetesLikely pathogenic
(Aug 18, 2021)
reviewed by expert panel
FDA Recognized Database
77.
GRCh37:
Chr12:121426706
GRCh38:
Chr12:120988903
HNF1AV133MMonogenic diabetesLikely pathogenic
(Jun 24, 2022)
reviewed by expert panel
FDA Recognized Database
78.
GRCh37:
Chr12:121426707-121426713
GRCh38:
Chr12:120988904-120988910
HNF1AV134fsMonogenic diabetesLikely pathogenic
(Jun 24, 2022)
reviewed by expert panel
FDA Recognized Database
79.
GRCh37:
Chr12:121426713
GRCh38:
Chr12:120988910
HNF1AD135fsMonogenic diabetesPathogenic
(Jul 1, 2022)
reviewed by expert panel
FDA Recognized Database
80.
GRCh37:
Chr12:121426713
GRCh38:
Chr12:120988910
HNF1AD135AMaturity onset diabetes mellitus in youngLikely pathogeniccriteria provided, single submitter
81.
GRCh37:
Chr12:121426725
GRCh38:
Chr12:120988922
HNF1AL139Pnot providedLikely pathogenic
(May 27, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr12:121426734
GRCh38:
Chr12:120988931
HNF1AS142FMonogenic diabetesPathogenic
(Aug 24, 2021)
reviewed by expert panel
FDA Recognized Database
83.
GRCh37:
Chr12:121426734
GRCh38:
Chr12:120988931
HNF1AH143fsMonogenic diabetesLikely pathogenic
(Oct 29, 2021)
reviewed by expert panel
FDA Recognized Database
84.
GRCh37:
Chr12:121426736
GRCh38:
Chr12:120988933
HNF1AH143YMonogenic diabetesPathogenic
(Aug 24, 2021)
reviewed by expert panel
FDA Recognized Database
85.
GRCh37:
Chr12:121426738
GRCh38:
Chr12:120988935
HNF1AH143QMonogenic diabetesLikely pathogenic
(Nov 3, 2021)
reviewed by expert panel
FDA Recognized Database
86.
GRCh37:
Chr12:121426740
GRCh38:
Chr12:120988937
HNF1AL144Rnot providedLikely pathogenic
(Apr 24, 2019)
criteria provided, single submitter
87.
GRCh37:
Chr12:121426743
GRCh38:
Chr12:120988940
HNF1AS145FMonogenic diabetesPathogenic
(Apr 8, 2022)
reviewed by expert panel
FDA Recognized Database
88.
GRCh37:
Chr12:121426759
GRCh38:
Chr12:120988956
HNF1AG151fsnot providedPathogenic
(Aug 6, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr12:121426776
GRCh38:
Chr12:120988973
HNF1AT156KMaturity-onset diabetes of the young type 3Likely pathogenic
(May 1, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr12:121426781
GRCh38:
Chr12:120988978
HNF1AK158*not providedPathogenic
(Oct 26, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr12:121426784
GRCh38:
Chr12:120988981
HNF1AR159GMonogenic diabetesLikely pathogenic
(Apr 9, 2022)
reviewed by expert panel
FDA Recognized Database
92.
GRCh37:
Chr12:121426784
GRCh38:
Chr12:120988981
HNF1AR159WMonogenic diabetesPathogenic
(Dec 22, 2021)
reviewed by expert panel
FDA Recognized Database
93.
GRCh37:
Chr12:121426785
GRCh38:
Chr12:120988982
HNF1AA160fsMaturity onset diabetes mellitus in youngPathogenic
(Feb 4, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr12:121426785
GRCh38:
Chr12:120988982
HNF1AR159QMonogenic diabetesPathogenic
(Dec 30, 2021)
reviewed by expert panel
FDA Recognized Database
95.
GRCh37:
Chr12:121426803
GRCh38:
Chr12:120989000
HNF1AW165*Monogenic diabetesPathogenic
(Jun 10, 2022)
reviewed by expert panel
FDA Recognized Database
96.
GRCh37:
Chr12:121426820
GRCh38:
Chr12:120989017
HNF1AR171Gnot provided, Maturity onset diabetes mellitus in youngPathogenic
(Oct 13, 2021)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr12:121426820
GRCh38:
Chr12:120989017
HNF1AR171*Monogenic diabetesPathogenic
(Apr 10, 2022)
reviewed by expert panel
FDA Recognized Database
98.
GRCh37:
Chr12:121426823-121426868
GRCh38:
Chr12:120989020-120989065
HNF1AMonogenic diabetesLikely pathogenic
(Apr 20, 2022)
reviewed by expert panel
FDA Recognized Database
99.
GRCh37:
Chr12:121426835
GRCh38:
Chr12:120989032
HNF1AQ176*Monogenic diabetesPathogenic
(Apr 10, 2022)
reviewed by expert panel
FDA Recognized Database
100.
GRCh37:
Chr12:121426836
GRCh38:
Chr12:120989033
HNF1AMaturity onset diabetes mellitus in youngPathogenic
(Jun 18, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination